XML 24 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes in Equity and Income - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Capital in Excess of Par
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2022     127,173,000        
Beginning balance at Dec. 31, 2022 $ 1,356,564 $ 1,121,922 $ 127 $ 452,183 $ 581,010 $ 88,602 $ 234,642
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 243,491 243,491     243,491    
Net income attributable to non-controlling interests 48,153 0         48,153
Cash dividends declared for common stockholders (63,904) (63,904)     (63,904)    
Issuance of restricted stock (in shares)     1,651,000        
Issuance of restricted stock 0 0 $ 1 (1)      
Forfeitures of unvested restricted stock (in shares)     (12,000)        
Forfeitures of unvested restricted stock 12 12 $ 0 0 12    
Vesting of restricted stock 43,619 43,619   43,619      
Repurchase of common shares (in shares)     (443,000)        
Repurchase of common shares (12,759) (12,759) $ 0 (5,184) (7,575)    
Issuance of non-controlling interests 23,051 1,870   1,870     21,181
Non-controlling interests acquired in business combination 9,007 0         9,007
Distributions to and purchases of non-controlling interests (55,314) (1,745)   927 (2,672)   (53,569)
Redemption value adjustment on non-controlling interests 1,527 1,527     1,527    
Other comprehensive loss (45,695) (45,695)       (45,695)  
Other (34) (34)   (1) (33)    
Ending balance (in shares) at Dec. 31, 2023     128,369,000        
Ending balance at Dec. 31, 2023 1,547,718 1,288,304 $ 128 493,413 751,856 42,907 259,414
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 214,038 214,038     214,038    
Net income attributable to non-controlling interests 73,264 0         73,264
Cash dividends declared for common stockholders (64,617) (64,617)     (64,617)    
Issuance of restricted stock (in shares)     1,728,000        
Issuance of restricted stock 0 0 $ 2 (2)      
Forfeitures of unvested restricted stock (in shares)     (69,000)        
Forfeitures of unvested restricted stock 71 71 $ 0 0 71    
Vesting of restricted stock 100,599 100,599   100,599      
Repurchase of common shares (in shares)     (1,065,000)        
Repurchase of common shares (37,905) (37,905) $ (1) (18,176) (19,728)    
Issuance of non-controlling interests 27,200 0       27,200
Non-controlling interests acquired in business combination 13,009 0         13,009
Distributions to and purchases of non-controlling interests (50,276) 394   394   (50,670)
Redemption value adjustment on non-controlling interests (1,947) (1,947)     (1,947)    
Concentra Separation and Distribution 208,552 225,196   334,852 (109,656)   (16,644)
Other comprehensive loss (42,907) (42,907)       (42,907)  
Other $ 129 129   129    
Ending balance (in shares) at Dec. 31, 2024 128,962,850   128,963,000        
Ending balance at Dec. 31, 2024 $ 1,986,928 1,681,355 $ 129 911,080 770,146 0 305,573
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 146,219 146,219     146,219    
Net income attributable to non-controlling interests 62,898 0         62,898
Cash dividends declared for common stockholders (31,435) (31,435)     (31,435)    
Issuance of restricted stock (in shares)     1,722,000        
Issuance of restricted stock 0 0 $ 2 (2)      
Forfeitures of unvested restricted stock (in shares)     (28,000)        
Forfeitures of unvested restricted stock 18 18 $ 0 0 18    
Vesting of restricted stock 16,684 16,684   16,684      
Repurchase of common shares (in shares)     (6,640,000)        
Repurchase of common shares (100,905) (100,905) $ (7) (52,970) (47,928)    
Issuance of non-controlling interests 15,904 0         15,904
Distributions to and purchases of non-controlling interests (72,972) 56   56     (73,028)
Redemption value adjustment on non-controlling interests (4) (4)     (4)    
Other comprehensive loss $ (6,404) (6,404)       (6,404)  
Ending balance (in shares) at Dec. 31, 2025 124,017,191   124,017,000        
Ending balance at Dec. 31, 2025 $ 2,016,931 $ 1,705,584 $ 124 $ 874,848 $ 837,016 $ (6,404) $ 311,347